IGF OncologyOffering
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.
CubCrafters has its own Skunk Works-like division called “Area X” Horgan ... ducted fans that work within ELAS are built in two-fan modules which can ... manufacturer to do so Horgan asserts and it has self-funded development in all ...
to understand your behavior and how it can impact your investment decisions. Here ... essential to be honest about how much risk you are comfortable taking. ... tolerance. Avoid getting caught up in the hype: It can be tempting to jump ...
rounds of NASA funding of our Electric Lift Augmenting Slats [ELAS] ... and performance, while working to improve and optimize our customer service ... https://marketplace.title3funds.com/offers/PreviewOffers/cub-crafters If you are an accredited investor, you can also invest via our ...
A+ IPO to the major exchanges, the offering starts as a simple Reg A+ and then just prior to the time of listing the format of the Reg A+ Offering ... that listing your company via Reg A+ on the OTCQB or OTCQX does not require ...
Costs For Reg D and Reg A+ STOs; Legal fee $12k- $50k depending ... Timeline Schedule for a Reg A+ STO Manhattan Street Capital STO program description Timeline for a Reg A+ STO via Convertible Notes ...
Invest in Fast-Growing Organic Agriculture Technology!
a Reg A+ capital raise. This will be most useful for OTCQB and OTCQX reporting companies because they can use Reg A+ to uplist or simply raise ...
Invest in Remote-Controlled Drug Delivery
How to invest; Make a reservation from the offering page, you ... offerings. What is RegA+Audition(TM)? Summary of Regulation A+ Latest Reg A ...